211 – 220 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
(
- Contribution to journal › Article
-
Mark
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
(
- Contribution to journal › Article
-
Mark
Två genombrott i behandling av typ 2-diabetes. Både receptoragonist och enzymhämmare har nu nått kliniken.
(
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibitors.
2007) In Baillière's Best Practice & Research in Clinical Endocrinology & Metabolism 21(4). p.517-533(
- Contribution to journal › Article
-
Mark
Omega-3 fatty acids and other PUFAs and weight control
2007)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Improved meal-related insulin processing contributes to the enhancement of B-Cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
GPR40 is expressed in glucagon producing cells and affects glucagon secretion.
(
- Contribution to journal › Article
- 2006
-
Mark
Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice.
(
- Contribution to journal › Article
-
Mark
Binding and the effect of the red kidney bean lectin, phytohaemagglutinin, in the gastrointestinal tract of suckling rats
(
- Contribution to journal › Article